JUST IN
You are here » Home » Company » Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd.

BSE: 532296 Sector: Health care
NSE: GLENMARK ISIN Code: INE935A01035
BSE 00:00 | 17 Aug 600.15 16.95
(2.91%)
OPEN

585.70

 HIGH

605.00

 LOW

585.70
NSE 00:00 | 17 Aug 600.15 16.90
(2.90%)
OPEN

585.00

 HIGH

604.85

 LOW

585.00
Add to Watchlist  |   Add to Portfolio
OPEN 585.70
PREVIOUS CLOSE 583.20
VOLUME 162218
52-Week high 656.00
52-Week low 483.60
P/E 14.84
Mkt Cap.(Rs cr) 16,936
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 585.70
CLOSE 583.20
VOLUME 162218
52-Week high 656.00
52-Week low 483.60
P/E 14.84
Mkt Cap.(Rs cr) 16,936
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

About Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd is a research-driven global integrated pharmaceutical company. The company is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology Respiratory and Dermatology. Its branded...> More

Glenmark Pharmaceuticals Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   16,936
EPS - TTM () [*S] 40.43
P/E Ratio (X) [*S] 14.84
Face Value ()   1
Latest Dividend (%)   200.00
Latest Dividend Date 20 Sep 2017
Dividend Yield (%) 0.33
Book Value / Share () [*S] 368.24
P/B Ratio () [*S] 1.63
[*C] Consolidated     [*S] Standalone    

News

Announcement

Glenmark Pharmaceuticals Ltd - Financial Results

Particulars ( cr) Jun 2018 Jun 2017 % Chg
Net Sales 2165.62 2363 -8.35
Other Income 138.22 15.29 803.99
Total Income 2303.83 2378.29 -3.13
Total Expenses 1818.73 1785.55 1.86
Operating Profit 485.1 592.74 -18.16
Net Profit 232.99 333.38 -30.11
Equity Capital 28.22 28.22 -
> More on Glenmark Pharmaceuticals Ltd Financials Results

Glenmark Pharmaceuticals Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Torrent Pharma. 1766.70 3.98 29896.10
Glaxosmi. Pharma 3303.40 0.61 27979.80
Alkem Lab 2091.95 2.57 25009.26
Glenmark Pharma. 600.15 2.91 16936.23
Abbott India 7782.25 2.87 16537.28
Sanofi India 6353.25 0.30 14631.54
Pfizer 3043.75 0.41 13925.16
> More on Glenmark Pharmaceuticals Ltd Peer Group

Glenmark Pharmaceuticals Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 46.54
Banks/FIs 2.74
FIIs 30.61
Insurance 0.00
Mutual Funds 4.01
Indian Public 10.71
Custodians 0.00
Other 5.20
> More on Glenmark Pharmaceuticals Ltd Share Holding Pattern

Glenmark Pharmaceuticals Ltd - Research Reports

Date Broker Action Price Report
03/05 HDFC Securities Buy 894 PDF IconDetails
20/12 IDBI Capital Accumulate 941 PDF IconDetails
> More on Glenmark Pharmaceuticals Ltd Research Reports

Glenmark Pharmaceuticals Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week 1.73% 1.54% 0.21% 0.36%
1 Month 6.58% 6.41% 3.91% 4.20%
3 Month 14.49% 14.19% 7.96% 7.38%
6 Month 15.02% 15.19% 11.58% 9.74%
1 Year -3.21% -3.11% 19.35% 15.82%
3 Year -46.86% -46.85% 36.12% 35.31%

Glenmark Pharmaceuticals Ltd - STOCK STRENGTH

Today's Low/High 585.70
605.00
Week Low/High 570.00
605.00
Month Low/High 547.65
605.00
YEAR Low/High 483.60
656.00
All TIME Low/High 1.89
1262.00

Browse STOCK Companies

Quick Links for Glenmark Pharmaceuticals: